Albert Fournier

3.6k total citations
40 papers, 1.5k citations indexed

About

Albert Fournier is a scholar working on Nephrology, Cardiology and Cardiovascular Medicine and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Albert Fournier has authored 40 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Nephrology, 10 papers in Cardiology and Cardiovascular Medicine and 8 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Albert Fournier's work include Parathyroid Disorders and Treatments (16 papers), Blood Pressure and Hypertension Studies (7 papers) and Renin-Angiotensin System Studies (6 papers). Albert Fournier is often cited by papers focused on Parathyroid Disorders and Treatments (16 papers), Blood Pressure and Hypertension Studies (7 papers) and Renin-Angiotensin System Studies (6 papers). Albert Fournier collaborates with scholars based in France, United States and Romania. Albert Fournier's co-authors include Jean‐Michel Achard, Jean Michel Achard, William J. Johnson, Claude D. Arnaud, Ralph S. Goldsmith, Ziad A. Massy, Sophie Liabeuf, P Morinière, Leonardo A. Fernandez and Gabriel Choukroun and has published in prestigious journals such as Journal of Clinical Investigation, Journal of the American College of Cardiology and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Albert Fournier

40 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Albert Fournier France 21 743 339 295 278 266 40 1.5k
A. Fournier France 21 586 0.8× 297 0.9× 240 0.8× 343 1.2× 216 0.8× 79 1.6k
Giovana Seno Di Marco Germany 19 757 1.0× 146 0.4× 214 0.7× 465 1.7× 149 0.6× 38 1.5k
Akira Kobayashi Japan 19 540 0.7× 186 0.5× 217 0.7× 221 0.8× 197 0.7× 87 1.5k
Marie‐Luise Gross Germany 20 519 0.7× 191 0.6× 397 1.3× 276 1.0× 190 0.7× 30 1.5k
Shin‐ichi Suga Japan 22 331 0.4× 252 0.7× 728 2.5× 473 1.7× 133 0.5× 37 1.7k
Maren Leifheit‐Nestler Germany 24 741 1.0× 149 0.4× 271 0.9× 519 1.9× 222 0.8× 50 1.5k
Hagop S. Aynedjian United States 26 618 0.8× 333 1.0× 296 1.0× 505 1.8× 83 0.3× 45 1.8k
Robert Faulhaber‐Walter United States 20 502 0.7× 127 0.4× 289 1.0× 619 2.2× 126 0.5× 32 1.6k
Michel Baum United States 17 433 0.6× 233 0.7× 60 0.2× 496 1.8× 149 0.6× 28 1.2k
Songcang Chen United States 20 205 0.3× 245 0.7× 425 1.4× 391 1.4× 1.0k 3.8× 32 1.9k

Countries citing papers authored by Albert Fournier

Since Specialization
Citations

This map shows the geographic impact of Albert Fournier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Albert Fournier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Albert Fournier more than expected).

Fields of papers citing papers by Albert Fournier

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Albert Fournier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Albert Fournier. The network helps show where Albert Fournier may publish in the future.

Co-authorship network of co-authors of Albert Fournier

This figure shows the co-authorship network connecting the top 25 collaborators of Albert Fournier. A scholar is included among the top collaborators of Albert Fournier based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Albert Fournier. Albert Fournier is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lenglet, Aurélie, et al.. (2013). Use of Nicotinamide to Treat Hyperphosphatemia in Dialysis Patients. Drugs in R&D. 13(3). 165–173. 30 indexed citations
2.
Barreto, Daniela Veit, Fellype Carvalho Barreto, Sophie Liabeuf, et al.. (2009). Vitamin D Affects Survival Independently of Vascular Calcification in Chronic Kidney Disease. Clinical Journal of the American Society of Nephrology. 4(6). 1128–1135. 123 indexed citations
3.
Segall, Liviu, Roxana Oprisiu, Albert Fournier, & Adrian Covic. (2008). Antihypertensive treatment and stroke prevention in patients with and without chronic kidney disease: a review of controlled trials. Journal of Nephrology. 21(3). 374–383. 4 indexed citations
4.
Faure, Sébastien, et al.. (2008). Protective effect of candesartan in experimental ischemic stroke in the rat mediated by AT2 and AT4 receptors. Journal of Hypertension. 26(10). 2008–2015. 39 indexed citations
5.
Monge, Matthieu, I. Shahapuni, Roxana Oprisiu, et al.. (2006). Reappraisal of 2003 NKF-K/DOQI guidelines for management of hyperparathyroidism in chronic kidney disease patients. Nature Clinical Practice Nephrology. 2(6). 326–336. 13 indexed citations
6.
Faure, Sébastien, et al.. (2006). Synergistic protective effects of erythropoietin and olmesartan on ischemic stroke survival and post-stroke memory dysfunctions in the gerbil. Journal of Hypertension. 24(11). 2255–2261. 37 indexed citations
7.
Shahapuni, I., Roxana Oprisiu, Matthieu Monge, et al.. (2005). Viewpoint: How Do Calcimimetics Fit Into the Management of Parathyroid Hormone, Calcium, and Phosphate Disturbances in Dialysis Patients?. Seminars in Dialysis. 18(3). 226–238. 18 indexed citations
8.
Fournier, Albert, Franz H. Messerli, Jean Michel Achard, & Leonardo A. Fernandez. (2004). Cerebroprotection mediated by angiotensin II. Journal of the American College of Cardiology. 43(8). 1343–1347. 88 indexed citations
9.
Ghez, David, Pierre‐François Westeel, Isabelle Henry, et al.. (2002). Control of a relapse and induction of long-term remission of Wegener's granulomatosis by cyclosporine. American Journal of Kidney Diseases. 40(2). e6.1–e6.3. 11 indexed citations
10.
Ferreira, Aníbal, José Guilherme Ferreira Marques Galvão, Jean‐Claude Souberbielle, et al.. (2001). Effect of type of dialysis membrane on bone in haemodialysis patients. Nephrology Dialysis Transplantation. 16(6). 1230–1238. 3 indexed citations
11.
Mazouz, Hakim, C Hottelart, Patrice Fardellone, et al.. (2000). Cyclosporine bone remodeling effect prevents steroid osteopenia after kidney transplantation. Kidney International. 58(4). 1788–1796. 53 indexed citations
12.
Fournier, Albert, Roxana Oprisiu, C Hottelart, et al.. (1998). Renal Osteodystrophy in Dialysis Patients: Diagnosis and Treatment. Artificial Organs. 22(7). 530–557. 26 indexed citations
13.
Bataille, Pierre, et al.. (1998). Pathophysiology and treatment of idiopathic hypercalciuria. Current Opinion in Rheumatology. 10(4). 373–388. 19 indexed citations
14.
Fournier, Albert, Roxana Oprisiu, A. Séchet, et al.. (1997). Invasive versus non-invasive diagnosis of renal bone disease. Current Opinion in Nephrology & Hypertension. 6(4). 333–348. 18 indexed citations
15.
Esper, I. El, et al.. (1997). Steady-state captopril renography: Continuous monitoring of the captopril-induced increase in99mTc-MAG3 mean parenchymal transit time in renovascular hypertension. European Journal of Nuclear Medicine and Molecular Imaging. 24(7). 739–744. 1 indexed citations
16.
Boudailliez, B, Pierre‐François Westeel, Jean‐Michel Achard, et al.. (1992). Prevention of Hyperparathyroidism in Patients on Maintenance Dialysis by Intravenous 1-Alpha-Hydroxyvitamin D<sub>3</sub> in Association with Mg(OH)<sub>2</sub> as Sole Phosphate Binder. ˜The œNephron journals/Nephron journals. 60(2). 154–163. 9 indexed citations
17.
Sebert, Jean‐Luc, B Boudailliez, P Morinière, et al.. (1991). Comparison of Intact, Midregion, and Carboxy Terminal Assays of Parathyroid Hormone for the Diagnosis of Bone Disease in Hemodialyzed Patients. The Journal of Clinical Endocrinology & Metabolism. 73(3). 516–524. 113 indexed citations
18.
Bataille, Pierre, Jean Michel Achard, Albert Fournier, et al.. (1991). Diet, vitamin D and vertebral mineral density in hypercalciuric calcium stone formers. Kidney International. 39(6). 1193–1205. 134 indexed citations
19.
Morinière, P, et al.. (1989). Use of Permcath (Quinton) Catheter in Uraemic Patients in Whom the Creation of Conventional Vascular Access for Haemodialysis Is Difficult. ˜The œNephron journals/Nephron journals. 53(4). 297–302. 34 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by A. Fournier Breakdown of academic impact, for papers by Giovana Seno Di Marco Breakdown of academic impact, for papers by Akira Kobayashi Breakdown of academic impact, for papers by Marie‐Luise Gross Breakdown of academic impact, for papers by Shin‐ichi Suga Breakdown of academic impact, for papers by Maren Leifheit‐Nestler Breakdown of academic impact, for papers by Hagop S. Aynedjian Breakdown of academic impact, for papers by Robert Faulhaber‐Walter Breakdown of academic impact, for papers by Michel Baum Breakdown of academic impact, for papers by Songcang Chen
Rankless by CCL
2026